Filter
716
Text search:
drug
dosing
Featured
102
195
Language
Document type
418
153
76
24
15
13
10
3
2
1
1
Countries / Regions
45
33
23
21
17
15
14
10
10
10
9
8
8
7
7
7
7
6
6
6
5
4
4
4
3
3
3
3
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
242
146
40
24
20
3
3
1
Toolboxes
108
85
62
34
32
24
20
17
11
8
6
5
5
4
3
2
2
2
1
Module: Disorders due to substance abuse mhGAP
recommended
Accessed: 21.03.2019
mhGAP Training Manual for the mhGAP Intervention Guide for mental, neurological and substance use disorders in non-specialized health settings – version 2.0 (for field testing)
Scoping Question: For adults and children living with HIV, which antiepileptic medications (such as phenobarbital, phenytoin, carbamazepine or valproic acid) produce benefits and/or harms when compared to a placebo or controls?
Attention-Deficit/Hyperactivity Disorder
SIGN 143. A national clinical guideline
Published May 2015, Revised 2018
Endorsed by the CCM Georgia on April 15th 2015
Accessed: 26.09.2019
Examining the infrastructure of the Russian and USA healthcare systems with respect to the management of HIV patients
Supplement to the 2016 consolidated Guidelines on the use of antiretroviral drugs for Treating and Preventing HIV infection
HIV Treatment
Supplement Article
www.jaids.com J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018
Accessed: 30.10.2019
Research Article
PLOS ONE | https://doi.org/10.1371/journal.pone.0192791 February 15, 2018
19 February 2021
The overall objective of this prospective meta-analyses (PMA) is to estimate the effect of anti-IL-6 therapy compared with usual care in hospitalized patients with suspected or confirmed COVID-19. The primary comparison is of the class effect of anti-IL-6 therapies. It will also es
...
Accessed February 6, 2020
Consolidated Guidelines
Geneva, 2016
The End TB Strategy
